SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer-Reference-Cited by-同舟云学术

SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

Published:2019-09 Issue: Volume:119 Page:158-167
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Munemoto Y.,Nakamura M.,Takahashi M.^ORCID,Kotaka M.,Kuroda H.,Kato T.,Minagawa N.,Noura S.,Fukunaga M.,Kuramochi H.,Touyama T.,Takahashi T.,Miwa K.,Satake H.,Kurosawa S.,Miura T.,Mishima H.,Sakamoto J.,Oba K.^ORCID,Nagata N.

Funder

Takeda Pharmaceutical Company Ltd.

Takeda Pharmaceutical Co. Limited

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study;Douillard;J Clin Oncol,2010

2. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer;Van Cutsem;J Clin Oncol,2007

3. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer;Peeters;J Clin Oncol,2010

4. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

5. A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration;Beijers;Support Care Cancer,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology;Current Oncology;2024-06-17

2. Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study;Journal of Clinical Oncology;2024-04-10

3. Efficacy of different maintenance strategies for RAS wild-type colorectal cancer: A network meta-analysis;Digestive and Liver Disease;2024-02

4. Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis;Critical Reviews in Oncology/Hematology;2023-11

5. Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer;JAMA Network Open;2023-09-18